Cargando…

Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings

To quantify the effect of hospital and community-based transmission and control measures on Clostridium difficile infection (CDI), we constructed a transmission model within and between hospital, community, and long-term care-facility settings. By parameterizing the model from national databases and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Durham, David P., Olsen, Margaret A., Dubberke, Erik R., Galvani, Alison P., Townsend, Jeffrey P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806959/ https://www.ncbi.nlm.nih.gov/pubmed/26982504 http://dx.doi.org/10.3201/eid2204.150455

Ejemplares similares

Burden of Clostridium difficile on the Healthcare System
por: Dubberke, Erik R., et al.
Publicado: (2012)

Outpatient Healthcare Settings and Transmission of Clostridium difficile
por: Jury, Lucy A., et al.
Publicado: (2013)

Increasing Age Has Limited Impact on Risk of Clostridium difficile Infection in an Elderly Population
por: Olsen, Margaret A, et al.
Publicado: (2018)

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)

The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases
por: Olsen, Margaret A., et al.
Publicado: (2016)

Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis
por: Dubberke, Erik R., et al.
Publicado: (2016)

Attributable Outcomes of Endemic Clostridium difficile–associated Disease in Nonsurgical Patients
por: Dubberke, Erik R., et al.
Publicado: (2008)

Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study
por: Stephenson, Brittany, et al.
Publicado: (2020)

Clostridium: Transmission difficile?
por: Harbarth, Stephan, et al.
Publicado: (2012)

Healthcare Costs of Clostridioides difficile Infection in Commercially Insured Younger Adults
por: Sahrmann, John M, et al.
Publicado: (2023)

Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2014)

Risk for Clostridium difficile Infection After Allogeneic Hematopoietic Cell Transplant Remains Elevated in the Postengraftment Period
por: Dubberke, Erik R., et al.
Publicado: (2017)

ICD-9 Codes and Surveillance for Clostridium difficile–associated Disease
por: Dubberke, Erik R., et al.
Publicado: (2006)

1033. Thinking Outside the Bowel: Clostridium difficile Bacteremia Case Series
por: Pettigrew, Adam, et al.
Publicado: (2018)

Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review
por: Gingras, Guillaume, et al.
Publicado: (2016)

Asymptomatic Clostridium difficile Colonisation and Onward Transmission
por: Eyre, David W., et al.
Publicado: (2013)

1646 Evidence of hospital-associated Clostridium difficile transmission between patients with asymptomatic carriage and patients with Clostridium difficile infection
por: Galdys, Alison, et al.
Publicado: (2014)

Quantifying Poverty as a Driver of Ebola Transmission
por: Fallah, Mosoka P., et al.
Publicado: (2015)

Clostridium difficile infection in an endemic setting in the Netherlands
por: Hensgens, M. P. M., et al.
Publicado: (2010)

113 Procedure-specific Surgical Site Infection (SSI) Prevalence Widely Varies within Certain NHSN (National Healthcare Safety Network) Surgery Groups
por: Saeed, Mohammed, et al.
Publicado: (2014)

Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
por: Dubberke, Erik R, et al.
Publicado: (2020)

Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model
por: Yakob, Laith, et al.
Publicado: (2013)

Microevolutionary analysis of Clostridium difficile genomes to investigate transmission
por: Didelot, Xavier, et al.
Publicado: (2012)

Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach
por: Desai, Kamal, et al.
Publicado: (2016)

CRISPR Diversity and Microevolution in Clostridium difficile
por: Andersen, Joakim M., et al.
Publicado: (2016)

752. Costs Attributable to Clostridioides difficile Infection in the Presence of Differential Mortality
por: Sahrmann, John, et al.
Publicado: (2021)

Pathogenicity Locus, Core Genome, and Accessory Gene Contributions to Clostridium difficile Virulence
por: Lewis, Brittany B., et al.
Publicado: (2017)

Clostridium difficile infection
por: Geller, Stephen A., et al.
Publicado: (2014)

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
por: Gerding, Dale N, et al.
Publicado: (2018)

1633 The Importance of Considering Different Healthcare Settings When Estimating the Incidence of Clostridium difficile
por: Kuntz, Jennifer, et al.
Publicado: (2014)

2322: The effects of fecal microbiota transplantation on the gut microbiota in subjects with Clostridium difficile infection
por: Elizabeth Langdon, Amy, et al.
Publicado: (2018)

Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study
por: Skoutelis, Athanasios, et al.
Publicado: (2017)

Binary Toxin and Death after Clostridium difficile Infection
por: Bacci, Sabrina, et al.
Publicado: (2011)

Controversies in Clostridium difficile testing
por: Fedorko, Daniel P.
Publicado: (2002)

Increased Incidence and Risk of Septicemia and Urinary Tract Infection After Clostridioides difficile Infection
por: Olsen, Margaret A, et al.
Publicado: (2023)

Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection
por: Prabhu, Vimalanand S, et al.
Publicado: (2017)

Patient and Strain Characteristics Associated With Clostridium difficile Transmission and Adverse Outcomes
por: Martin, Jessica S H, et al.
Publicado: (2018)

Prevalence of Clostridium difficile colonization among healthcare workers
por: Friedman, N Deborah, et al.
Publicado: (2013)

Enhanced Cleaning and Education to Prevent Transmission of Clostridium difficile in Pediatrics
por: Aslam, Anoshé, et al.
Publicado: (2017)

2428. Whole-genome Sequencing to Determine Clostridium difficile Transmission
por: Madigan, Victoria M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_941c43354tvf8q9j88fv2s6q8b